153 related articles for article (PubMed ID: 26315087)
1. Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression.
Ma PL; Peng XX; Du B; Hu XL; Gong YC; Wang Y; Xi XM
Chin Med J (Engl); 2015 Sep; 128(17):2374-82. PubMed ID: 26315087
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.
He B; Xu B; Xu X; Li L; Ren R; Chen Z; Xiao J; Wang Y; Xu B
Crit Care; 2015 Mar; 19(1):92. PubMed ID: 25886952
[TBL] [Abstract][Full Text] [Related]
3. Fluid resuscitation in sepsis: a systematic review and network meta-analysis.
Rochwerg B; Alhazzani W; Sindi A; Heels-Ansdell D; Thabane L; Fox-Robichaud A; Mbuagbaw L; Szczeklik W; Alshamsi F; Altayyar S; Ip WC; Li G; Wang M; Wludarczyk A; Zhou Q; Guyatt GH; Cook DJ; Jaeschke R; Annane D;
Ann Intern Med; 2014 Sep; 161(5):347-55. PubMed ID: 25047428
[TBL] [Abstract][Full Text] [Related]
4. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.
Zarychanski R; Abou-Setta AM; Turgeon AF; Houston BL; McIntyre L; Marshall JC; Fergusson DA
JAMA; 2013 Feb; 309(7):678-88. PubMed ID: 23423413
[TBL] [Abstract][Full Text] [Related]
5. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.
Patel A; Waheed U; Brett SJ
Intensive Care Med; 2013 May; 39(5):811-22. PubMed ID: 23430019
[TBL] [Abstract][Full Text] [Related]
6. Colloid solutions for fluid resuscitation in patients with sepsis: systematic review of randomized controlled trials.
Zhong JZ; Wei D; Pan HF; Chen YJ; Liang XA; Yang ZY; Tang HB
J Emerg Med; 2013 Oct; 45(4):485-95. PubMed ID: 23932700
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.
Raiman M; Mitchell CG; Biccard BM; Rodseth RN
Eur J Anaesthesiol; 2016 Jan; 33(1):42-8. PubMed ID: 26351826
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyethyl starch in sepsis.
Haase NR
Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
[TBL] [Abstract][Full Text] [Related]
10. Use of hydroxyethyl starch in sepsis research: A systematic review with meta-analysis.
Johansen JR; Perner A; Brodtkorb JH; Møller MH
Acta Anaesthesiol Scand; 2021 Nov; 65(10):1355-1364. PubMed ID: 34309830
[TBL] [Abstract][Full Text] [Related]
11. Early goal-directed therapy in the management of severe sepsis or septic shock in adults: a meta-analysis of randomized controlled trials.
Zhang L; Zhu G; Han L; Fu P
BMC Med; 2015 Apr; 13():71. PubMed ID: 25885654
[TBL] [Abstract][Full Text] [Related]
12. Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies.
Bansal M; Farrugia A; Balboni S; Martin G
Curr Drug Saf; 2013 Sep; 8(4):236-45. PubMed ID: 23909705
[TBL] [Abstract][Full Text] [Related]
13. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis.
Rochwerg B; Alhazzani W; Gibson A; Ribic CM; Sindi A; Heels-Ansdell D; Thabane L; Fox-Robichaud A; Mbuagbaw L; Szczeklik W; Alshamsi F; Altayyar S; Ip W; Li G; Wang M; Włudarczyk A; Zhou Q; Annane D; Cook DJ; Jaeschke R; Guyatt GH;
Intensive Care Med; 2015 Sep; 41(9):1561-71. PubMed ID: 25904181
[TBL] [Abstract][Full Text] [Related]
14. Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials.
Chen X; Zhu W; Tan J; Nie H; Liu L; Yan D; Zhou X; Sun X
Oncotarget; 2017 Apr; 8(16):27510-27519. PubMed ID: 28460438
[TBL] [Abstract][Full Text] [Related]
15. Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis.
Wiedermann CJ
Chin Med J (Engl); 2016 Jan; 129(1):116-7. PubMed ID: 26712449
[No Abstract] [Full Text] [Related]
16. Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials.
Wiedermann CJ; Joannidis M
Swiss Med Wkly; 2012; 142():w13656. PubMed ID: 22847748
[TBL] [Abstract][Full Text] [Related]
17. The effect of early goal-directed therapy on mortality in patients with severe sepsis and septic shock: a meta-analysis.
Lu J; Wang X; Chen Q; Chen M; Cheng L; Dai L; Jiang H; Sun Z
J Surg Res; 2016 May; 202(2):389-97. PubMed ID: 27229114
[TBL] [Abstract][Full Text] [Related]
18. [The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock].
Lv J; Zhao HY; Liu F; An YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):38-41. PubMed ID: 22248750
[TBL] [Abstract][Full Text] [Related]
19. Molecular weight and molar substitution are more important in HES-induced renal impairment than concentration after hemorrhagic and septic shock.
Simon TP; Thiele C; Schuerholz T; Fries M; Stadermann F; Haase G; Amann KU; Marx G
Minerva Anestesiol; 2015 Jun; 81(6):608-18. PubMed ID: 25296880
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
Müller RB; Haase N; Lange T; Wetterslev J; Perner A
Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
